spn-810
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jul 31, 2018 (NCT03597503)
Timeline
Indications
Mechanism of action
- Serotonin 2b (5-HT2b) receptorANTAGONIST
HTR2B antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03638466 | Phase 2 | Sep 10, 2018 | Supernus Pharmaceuticals |
| NCT03597503 | Phase 3 | Jul 31, 2018 | Supernus Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Supernus Pharmaceuticals | For profit | 2 | 2 | 2 | 2018 |
1 organizations
Page 1 / 1